Vascular targeting: Recent advances and therapeutic perspectives

Trends in Cardiovascular Medicine

Volumn 16, Issue 3, 2006, Pages 80-88

  Hajitou, Amin ^a   Pasqualini, Renata ^a   Arap, Wadih ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; ANGIOGENESIS INHIBITOR; CD51 ANTIGEN; CELL SURFACE RECEPTOR; DIPEPTIDYL CARBOXYPEPTIDASE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; GELATINASE A; GELATINASE B; GLUCOSE REGULATED PROTEIN 78; HEAT SHOCK PROTEIN 90; HYBRID PROTEIN; INTERLEUKIN 11 RECEPTOR; LIPOSOME; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; NERVE GROWTH FACTOR; PEPTIDE; PEPTIDE LIBRARY; VASCULAR CELL ADHESION MOLECULE 1; VASCULAR TARGETING AGENT; VASCULOTROPIN; VASCULOTROPIN RECEPTOR; VASCULOTROPIN RECEPTOR 1; VASCULOTROPIN RECEPTOR 2; VITRONECTIN RECEPTOR;

ADENOVIRUS VECTOR; AMINO ACID SEQUENCE; ANGIOGENESIS; CELL KILLING; CELLULAR DISTRIBUTION; COMBINATORIAL LIBRARY; CORONARY ARTERY ATHEROSCLEROSIS; ENDOTHELIUM INJURY; GENE INSERTION; GENETIC ENGINEERING; GENETIC TRANSDUCTION; HUMAN; ISOTOPE LABELING; LIGAND BINDING; MOLECULAR PROBE; NANOPARTICLE; NONVIRAL GENE DELIVERY SYSTEM; PHAGE DISPLAY; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN MICROARRAY; PROTEIN MOTIF; PROTEIN PROTEIN INTERACTION; PROTEIN TARGETING; RETROVIRUS VECTOR; REVIEW; SEQUENCE ANALYSIS; SEROTYPE; TARGET CELL DESTRUCTION; VASCULAR ENDOTHELIUM; VIRAL GENE DELIVERY SYSTEM; VIRION; VIRUS CAPSID; VIRUS INFECTIVITY; VIRUS PARTICLE; VIRUS RECOMBINANT;

ANIMALS; CARDIOVASCULAR DISEASES; DRUG DELIVERY SYSTEMS; ENDOTHELIUM, VASCULAR; GENE TARGETING; HUMANS; INFLAMMATION; LIGANDS; NEOPLASMS; PEPTIDE LIBRARY; RECEPTORS, CELL SURFACE;

EID: 33644994202     PISSN: 10501738     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tcm.2006.01.003     Document Type: Review

References (127)

1. GP Adams Improving the tumor specificity and retention of antibody-based molecules In Vivo 12 1998 11 21
2. W Arap, R Pasqualini, and E Ruoslahti Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model Science 279 1998 377 380
3. W Arap, M Kolonin, and M Trepel Steps toward mapping the human vasculature by phage display Nat Med 8 2002 121 127
4. MA Arap, J Lahdenranta, and PJ Mintz Cell surface expression of the stress response chaperone GRP78 enables tumor targeting by circulating ligands Cancer Cell 6 2004 275 284
5. CF Barbas, DR Burton, and JK Scott Phage Display: a Laboratory Manual 2000 Cold Spring Harbor Press New York
6. PA Barrow, and JS Soothill Bacteriophage therapy and prophylaxis: Rediscovery and renewed assessment of potential Trends Microbiol 5 1997 268 271
7. MV Blagosklonny Antiangigogenic therapy and tumor progression Cancer Cell 5 2004 13 17
8. WA Boisvert, AS Black, and LK Curtiss ApoA1 reduces free cholesterol accumulation in atherosclerotic lesions of ApoE-deficient mice transplanted with ApoE-expressing macrophages Arterioscler Thromb Vasc Biol 19 1999 525 530
9. L Borsi, E Balza, and M Bestagno Selective targeting of tumoral vasculature: comparison of different formats of an antibody (L19) to the ED-B domain of fibronectin Int J Cancer 102 2002 75 85
10. K Bosslet, R Straub, and M Blumrich Elucidation of the mechanism enabling tumor selective prodrug monotherapy Cancer Res 58 1998 1195 1201
11. G Bradley, PF Juranka, and V Ling Mechanism of multidrug resistance Biochim Biophys Acta 948 1988 87 128
12. RA Brekken, and PE Thorpe Vascular endothelial growth factor and vascular targeting of solid tumors Anticancer Res 21 2001 4221 4229
13. RA Brekken, C Li, and S Kumar Strategies for vascular targeting in tumors Int J Cancer 100 2002 123 130
14. PC Brooks, RA Clark, and DA Cheresh Requirement of vascular integrin alpha v beta 3 for angiogenesis Science 264 1994 569 571
15. PC Brooks, AM Montgomery, and M Rosenfeld Integrin αvβ3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels Cell 79 1994 1157 1164
16. F Buchegger, CM Haskell, and M Schreyer Radiolabeled fragments of monoclonal antibodies against carcinoembryonic antigen for localization of human colon carcinoma grafted into nude mice J Exp Med 158 1983 413 427
17. MA Burg, R Pasqualini, and W Arap NG2 proteoglycan-binding peptides target tumor neovasculature Cancer Res 59 1999 2869 2874
18. FJ Burrows, and PE Thorpe Eradication of large solid tumors in mice with an immunotoxin directed against tumor vasculature Proc Natl Acad Sci U S A 90 1993 8996 9000
19. B Carnemolla, L Borsi, and E Balza Enhancement of the antitumor properties of interleukin-2 by its targeted delivery to the tumor blood vessel extracellular matrix Blood 99 2002 1659 1665
20. M Chillon, A Bosch, and J Zabner Group D adenoviruses infect primary central nervous system cells more efficiently than those from subgroup C J Virol 73 1999 2537 2540
21. F Curnis, A Sacchi, and L Borgna Enhancement of tumor necrosis factor α antitumor immunotherapeutic properties by targeted delivery to aminopeptidase N (CD13) Nat Biotechnol 18 2000 1185 1190
22. F Curnis, A Gasparri, and A Sacchi Targeted delivery of IFN gamma to tumor vessels uncouples antitumor from counterregulatory mechanisms Cancer Res 65 2005 2906 2913
23. LK Curtiss, and WA Boisvert Apolipoprotein E and atherosclerosis Curr Opin Lipidol 11 2000 243 251
24. MI Cybulsky, and JRMA Gimbrone Endothelial expression of a mononuclear leukocyte adhesion molecule during atherogenesis Science 251 1991 788 791
25. S Demartis, L Tarli, and L Borsi Selective targeting of tumour neovasculature by a radiohalogenated human antibody fragment specific for the ED-B domain of fibronectin Eur J Nucl Med 28 2001 534 539
26. EB Dickerson, N Akhtar, and H Steinberg Enhancement of the antiangiogenic activity of interleukin-12 by peptide targeted delivery of the cytokine to αvβ3 integrin Mol Cancer Res 2 2004 663 673
27. A Dienst, A Grunow, and M Unruh Specific occlusion of murine and human tumor vasculature by VCAM-1-targeted recombinant fusion proteins J Natl Cancer Inst 97 2005 733 747
28. ZM Dong, SM Chapman, and AA Brown The combined role of P- and E-selectins in atherosclerosis J Clin Invest 102 1998 145 152
29. HM Ellerby, W Arap, and LM Ellerby Anti-cancer activity of targeted pro-apoptotic peptides Nat Med 5 1999 1032 1038
30. A Fahr, K Muller, and T Nahde A new colloidal lipidic system for gene therapy J Liposome Res 12 2002 37 44
31. S Folli, A Pelegrin, and Y Chalandon Tumor-necrosis factor can enhance radio-antibody uptake in human colon carcinoma xenografts by increasing vascular permeability Int J Cancer 53 1993 829 836
32. J Folkman Tumor angiogenesis: therapeutic implications N Engl J Med 285 1971 1182 1186
33. J Folkman Angiogenesis in cancer, vascular, rheumatoid and other disease Nat Med 1 1995 27 31
34. J Folkman VT DeVita S Hellman SA Rosenberg Cancer: Principles and practice of oncology 1997 Lippincott Philadelphia 3075 3085
35. BA French, W Mazur, and NM Ali Percutaneous transluminal in vivo gene transfer by recombinant adenovirus in normal porcine coronary arteries, atherosclerotic arteries, and two models of coronary restenosis Circulation 90 1994 2402 2413
36. V Fuster Mechanisms leading to myocardial infarction: insights from studies of vascular biology Circulation 90 1994 2126 2146
37. ZS Galis, and JJ Khatri Matrix metalloproteinases in vascular remodeling and atherogenesis: the good, the bad, and the ugly Circ Res 90 2002 251 262
38. RJ Giordano, M Cardo-Vila, and J Lahdenranta Biopanning and rapid analysis of selective interactive ligands Nat Med 7 2001 1249 1253
39. A Girod, M Ried, and C Wobus Genetic capsid modifications allow efficient re-targeting of adeno-associated virus type 2 Nat Med 5 1999 1052 1056
40. C Grines, M Watkins, and G Helmer Angiogenic Gene Therapy (AGENT) trial in patients with stable angina pectoris Circulation 105 2002 1291 1297
41. C Halin, S Rondini, and F Nilsson Enhancement of the antitumor activity of interleukin-12 by targeted delivery to neovasculature Nat Biotechnol 20 2002 264 269
42. HP Hammes, M Brownlee, and A Jonczyk Subcutaneous injection of a cyclic peptide antagonist of vitronectin receptor-type integrins inhibits retinal neovascularization Nat Med 2 1996 529 533
43. OA Harari, TJ Wickham, and CJ Stocker Targeting an adenoviral gene vector to cytokine-activated vascular endothelium via E-selectin Gene Ther 6 1999 801 807
44. MJ Havenga, AA Lemckert, and JM Grimbergen Improved adenovirus vectors for infection of cardiovascular tissues J Virol 75 2001 3335 3342
45. M Hedman, J Hartikainen, and M Syvanne Safety and feasibility of catheter-based local intracoronary vascular endothelial growth factor gene transfer in the prevention of postangioplasty and in-stent restenosis and in the treatment of chronic myocardial ischemai. Phase II results of the Kupoio Angiogenesis Trial (KAT) Circulation 107 2003 2677 2683
46. RW Hendrix Evolution: the long evolutionary reach of viruses Curr Biol 9 1999 R914 R917
47. K Hida, and M Klagsburn A new perspective on tumor endothelial cells: unexpected chromosome and centrosome abnormalities Cancer Res 65 2005 2507 2510
48. JD Hood, M Bednarski, and R Frausto Tumor regression by targeted gene delivery to the neovasculature Science 296 2002 2404 2407
49. P Hu, J Yan, and J Sharifi Comparison of three different targeted tissue factor fusion proteins for inducing tumor vessel thrombosis Cancer Res 63 2003 5046 5053
50. X Huang, G Molema, and S King Tumor infarction in mice by antibody-directed targeting of tissue factor to tumor vasculature Science 275 1997 547 550
51. VV Ivanenkov, F Felici, and AG Menon Targeted delivery of multivalent phage display vectors into mammalian cells Biochim Biophys Acta 1448 1999 463 472
52. RK Jain Transport of molecules in the tumor interstitium: a review Cancer Res 47 1987 3039 3051
53. N Jin, W Chen, and B Blazar Gene therapy of murine solid tumors with T cells transduced with a retroviral vascular endothelial growth factor-immunotoxin target gene Hum Gene Ther 13 2002 497 508
54. A Kamal, MF Boehm, and FJ Burrows Therapeutic and diagnostic implications of Hsp90 activation Trends Mol Med 10 2004 283 290
55. MA Kay, CS Manno, and MV Ragni Evidence for gene transfer and expression of factor IX in haemophilia B patients treated with an AAV vector Nat Genet 24 2000 257 261
56. DJ King, A Turner, and AP Farnsworth Improved tumor targeting with chemically cross-linked recombinant antibody fragments Cancer Res 54 1994 6176 6185
57. E Koivunen, W Arap, and H Valtanen Tumor targeting with a selective gelatinase inhibitor Nat Biotechnol 17 1999 768 774
58. MG Kolonin, R Pasqualini, and W Arap Molecular addresses in blood vessels as targets for therapy Curr Opin Chem Biol 5 2001 308 313
59. MG Kolonin, R Pasqualini, and W Arap Teratogenicity induced by targeting a placental immunoglobulin transporter Proc Natl Acad Sci U S A 99 2002 13055 13060
60. MG Kolonin, PK Saha, and L Chan Reversal of obesity by targeted ablation of adipose tissue Nat Med 10 2004 625 632
61. K Kunath, T Merdan, and O Hegener Integrin targeting using RGD-PEI conjugates for in vitro gene transfer J Gene Med 5 2003 588 599
62. D Larocca, A Witte, and W Johnson Targeting bacteriophage to mammalian cell surface receptors for gene delivery Hum Gene Ther 9 1998 2393 2399
63. D Larocca, PD Kassner, and A Witte Gene transfer to mammalian cells using genetically targeted filamentous bacteriophage FASEB J 13 1999 727 734
64. RT Lee, and P Libby Matrix metalloproteinases: not-so-innocent bystanders in heart failure J Clin Invest 106 2000 827 828
65. P Lemarchand, M Jones, and I Yamada In vivo gene transfer and expression in normal uninjured blood vessels using replication-deficient recombinant adenovirus vectors Circ Res 72 1993 1132 1138
66. P Libby Inflammation in atherosclerosis Nature 420 2002 868 874
67. A Lieber AAV display-homing in on the target Nat Biotechnol 21 2003 1011 1013
68. C Liu, G Bhattacharjee, and W Boisvert In vivo interrogation of the molecular display of atherosclerotic lesion surfaces Am J Pathol 163 2003 1859 1871
69. S Marchiò, J Lahdenranta, and RO Schlingemann Aminopeptidase A is a functional target in angiogenic blood vessels Cancer Cell 5 2004 151 162
70. C Mari, and HW Strauss Radiotracer characterization of coronary artery lesions Nucl Med Commun 23 2002 703 706
71. R Masood, EM Gordon, and MD Whitley Retroviral vectors bearing IgG-binding motifs for antibody-mediated targeting of vascular endothelial growth factor receptors Int J Mol Med 8 2001 335 343
72. PJ Mintz, J Kim, and KA Do Fingerprinting the circulating repertoire of antibodies from cancer patients Nat Biotechnol 21 2003 57 63
73. P Monaci, L Urbanelli, and L Fontana Phage as gene delivery vectors Curr Opin Mol Ther 3 2001 159 169
74. O Muller, F Kaul, and M Weitzman Random peptide libraries displayed on adeno-associated virus to select for targeted gene therapy vectors Nat Biotechnol 21 2003 1040 1046
75. S Nicklin, S White, and S Watkins Selective targeting of gene transfer to vascular endothelial cells by use of peptides isolated by phage display Circulation 102 2000 231 237
76. S Nicklin, H Buening, and K Dishart Efficient and selective AAV2-mediated gene transfer directed to human vascular endothelial cells Mol Ther 4 2001 174 181
77. S Nicklin, and A Baker Tropism-modified adenoviral and adeno-associated viral vectors for gene therapy Curr Gene Ther 2 2002 273 293
78. S Nicklin, S White, and C Nicol In vitro and in vivo characterisation of endothelial cell selective adenoviral vectors J Gene Med 6 2004 300 308
79. F Nilsson, H Kosmehl, and L Zardi Targeted delivery of tissue factor to the ED-B domain of fibronectin, a marker of angiogenesis, mediates the infarction of solid tumors in mice Cancer Res 61 2001 711 716
80. P Oh, Y Li, and J Yu Subtractive proteomic mapping of the endothelial surface in lung and solid tumours for tissue-specific therapy Nature 429 2004 629 635
81. K Pajusola, M Gruchala, and H Joch Cell-type-specific characteristics modulate the transduction efficiency of adeno-associated virus type 2 and restrain infection of endothelial cells J Virol 76 2002 11530 11540
82. R Pasqualini, and E Ruoslahti Organ targeting in vivo using phage display peptide libraries Nature 380 1996 364 366
83. R Pasqualini, E Koivunen, and E Ruoslahti αv integrins as receptors for tumor targeting by circulating ligands Nat Biotechnol 15 1997 542 546
84. R Pasqualini, E Koivunen, and R Kain Aminopeptidase N is a receptor for tumor-homing peptides and a target for inhibiting angiogenesis Cancer Res 60 2000 722 727
85. R Pasqualini, R Arap, and W Rajotte In vivo phage display CF Barbas DR Burton JK Scott Phage display: a laboratory manual 2000 Cold Spring Harbor Laboratory Press Cold Spring Harbor, NY 1 24 chap 22
86. RD Pentz, AL Flamm, and R Pasqualini Revisiting ethical guidelines for research with terminal wean and brain-dead participants Hastings Cent Rep 33 2003 20 26
87. RD Pentz, CB Cohen, and M Wicclair Ethics guidelines for research with the recently dead Nat Med 11 2005 1145 1149
88. S Piersanti, G Cherubini, and Y Martina Mammalian cell transduction and internalization properties of lambda phages displaying the full-length adenoviral penton base or its central domain J Mol Med 82 2004 467 476
89. MA Poul, and JD Marks Targeted gene delivery to mammalian cells by filamentous bacteriophage J Mol Biol 288 1999 203 211
90. T Pulli, E Koivunen, and T Hyypia Cell-surface interactions of echovirus 22 J Biol Chem 272 1997 21176 21180
91. R Pyo, JK Lee, and JM Shipley Targeted gene disruption of matrix metalloproteinase-9 (gelatinase B) suppresses development of experimental abdominal aortic aneurysms J Clin Invest 105 2000 1641 1649
92. D Rajotte, W Arap, and M Hagedorn Molecular heterogeneity of the vascular endothelium revealed by in vivo phage display J Clin Invest 102 1998 430 437
93. S Ran, B Gao, and S Duffy Infarction of solid Hodgkin's tumors in mice by antibody-directed targeting of tissue factor to tumor vasculature Cancer Res 58 1998 4646 4653
94. PN Reynolds, KR Zinn, and VD Gavrilyuk A targetable, injectable adenoviral vector for selective gene delivery to pulmonary endothelium in vivo Mol Ther 2 2000 562 578
95. M Richter, A Iwata, and J Nyhuis Adeno-associated virus vector transduction of vascular smooth muscle cells in vivo Physiol Genomics 2 2000 117 127
96. R Ross The pathogenesis of atherosclerosis: a perspective for the 1990s Nature 362 1993 801 809
97. R Ross Atherosclerosis: current understanding of mechanisms and future strategies in therapy Transplant Proc 25 1993 2041 2043
98. W Ruf, A Rehemtulla, and JH Morrissey Phospholipid-independent and -dependent interactions required for tissue factor receptor and cofactor function J Biol Chem 266 1991 16256
99. MJ Savontaus, BV Sauter, and TG Huang Transcriptional targeting of conditionally replicating adenovirus to dividing endothelial cells Gene Ther 9 2002 972 979
100. RM chiffelers, A Ansari, and J Xu Cancer siRNA therapy by tumor selective delivery with ligand-targeted sterically stabilized nanoparticle Nucleic Acid Res 32 2004 e149
101. JK Scott, and GP Smith Searching for peptide ligands with an epitope library Science 249 1990 386 390
102. GL Semenza Surviving ischemia: adaptive responses mediated by hypoxia-inducible-factor-1 J Clin Invest 106 2000 809 812
103. S Sengupta, D Eavarone, and I Capila Temporal targeting of tumour cells and neovasculature with a nanoscale delivery system Nature 436 2005 568 572
104. TR Shockley, K Lin, and JA Nagy Penetration of tumor tissue by antibodies and other immunoproteins Ann N Y Acad Sci 618 1991 367 382
105. DA Sipkins, DA Cheresh, and MR Kazemi Detection of tumor angiogenesis in vivo by alphaVbeta3-targeted magnetic resonance imaging Nat Med 4 1998 623 626
106. W Suh, SO Han, and L Yu An angiogenic, endothelial-cell-targeted polymeric gene carrier Mol Ther 6 2002 664 672
107. B St Croix, C Rago, and V Velculescu Genes expressed in human tumor endothelium Science 289 2000 1197 1202
108. L Tarli, E Balza, and F Viti A high-affinity human antibody that targets tumoral blood vessels Blood 94 1999 192 198
109. G Tepe, SH Duda, and J Meding Tc-99m-labeled endothelin derivative for imaging of experimentally induced atherosclerosis Atherosclerosis 157 2001 383 392
110. PE Thorpe, and FJ Burrows Antibody-directed targeting of the vasculature of solid tumors Breast Cancer Res Treat 36 1995 237 251
111. PE Thorpe, DJ Chaplin, and DC Blakey The first international conference on vascular targeting: meeting overview Cancer Res 63 2003 1144 1147
112. PE Thorpe Vascular targeting agents as cancer therapeutics Clin Cancer Res 10 2004 415 427
113. J Tran, Z Master, and JL Yu A role for surviving in chemoresistance of endothelial cells mediated by VEGF Proc Natl Acad Sci U S A 99 2002 4349 4354
114. M Trepel, M Grifman, and MD Weitzman Molecular adaptors for vascular-targeted adenoviral gene delivery Hum Gene Ther 11 2000 1971 1981
115. M Trepel, W Arap, and R Pasqualini Exploring vascular heterogeneity for gene therapy targeting Gene Ther 7 2000 2059 2060
116. M Trepel, W Arap, and R Pasqualini In vivo phage display and vascular heterogeneity: implications for targeted medicine Curr Opin Chem Biol 6 2002 399 404
117. LM Veenendaal, H Jin, and S Ran In vitro and in vivo studies of a VEGF121rGelonin chimeric fusion toxin targeting the neovasculature of solid tumors Proc Natl Acad Sci U S A 99 2002 7866 7871
118. CI Vidal, PJ Mintz, and K Lu An HSP90-mimic peptide revealed by fingerprinting the pool of antibodies from ovarian cancer patients Oncogene 23 2004 8859 8867
119. S White, S Nicklin, and H Buening Gene delivery to vascular tissue in vivo by tropism-modified adeno-associated virus vectors Circulation 109 2004 513 519
120. TJ Wickham, P Mathias, and DA Cheresh Integrins alpha v beta 3 and alpha v beta 5 promote adenovirus internalization but not virus attachment Cell 73 1993 309 319
121. TJ Wickham, D Haskard, and D Segal Targeting endothelium for gene therapy via receptors up-regulated during angiogenesis and inflammation Cancer Immunol Immunother 45 1997 149 151
122. AM Wu, W Chen, and A Raubitschek Tumor localization of anti-CEA single-chain Fvs: improved targeting by non-covalent dimers Immunotechnology 2 1996 21 36
123. CL Yeager, RA Ashmun, and RK Williams Human aminopeptidase N is a receptor for human coronavirus 229E Nature 357 1992 420 422
124. JL Yu, JW Rak, and BL Coomber Effect of p53 status on tumor response to anti-angiogenic therapy Science 295 2002 1526 1528
125. AN Zacher, CA Stock, and JW Golden A new filamentous phage cloning vector: fd-tet Gene 9 1980 127 140
126. AJ Zurita, W Arap, and R Pasqualini Mapping tumor vascular diversity by screening phage display libraries J Control Release 91 2003 183 186
127. AJ Zurita, P Troncoso, and M Cardo-Vila Combinatorial screenings in patients: the interleukin-11 receptor alpha as a candidate target in the progression of human prostate cancer Cancer Res 64 2004 435 439